OR WAIT null SECS
June 10, 2025
Article
If approved, mavorixafor will be the second FDA-approved treatment and the first oral medication for CN.
June 05, 2025
Investigators compared the medications across various patient cohorts with different causes of anemia, finding evidence almost uniformly in favor of FCM.
June 04, 2025
A recent analysis reveals no significant difference between restrictive and liberal transfusion strategies on quality of life in patients with myocardial infarction and anemia.
June 03, 2025
This FDA News Month in Review provides a round-up of regulatory decisions from May 2025.
A relatively quiet month for hematology, marked by brief ups and downs for trials and new research on anemia and sickle cell disease.
June 02, 2025
Investigators examined emergency department utilization as a product of age, patient-reported severity of vaso-occlusive episodes, and Social Vulnerability Index score.
May 30, 2025
Iron deficient diets can lead to anemia and various other health complications in adulthood.
May 28, 2025
Iron deficiency affects millions globally, especially women, yet remains underdiagnosed. Regular screening can prevent severe health issues and improve lives.
May 27, 2025
Prothena halts birtamimab development after missing key Phase 3 trial endpoints for AL amyloidosis, prompting workforce reductions and cost-cutting measures.
May 24, 2025
Stay updated with the latest healthcare breakthroughs, including FDA approvals and innovative treatments, in this week's essential news roundup for professionals.
